@article{bc63d86f60204126882880772cbb686a,
title = "Erratum: Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront immunotherapy responsiveness (Annals of oncology : official journal of the European Society for Medical Oncology (2012) 23 9 (2356-2362))",
author = "Czuczman, \{M. S.\} and Leonard, \{J. P.\} and S. Jung and Johnson, \{J. L.\} and Hsi, \{E. D.\} and Byrd, \{J. C.\} and Cheson, \{B. D.\}",
year = "2018",
month = nov,
day = "1",
doi = "10.1093/annonc/mdx812",
language = "English",
volume = "29",
pages = "2271",
journal = "Annals of oncology : official journal of the European Society for Medical Oncology",
issn = "0923-7534",
number = "11",
}